Rare diseases
Investigational molecules
Locations
Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) in Rotterdam, The Netherlands specialises in clinical trials of conditions such as Non-small cell lung cancer, Plasma cell myeloma, Hidradenitis, Neoplasm, and other specialisations. This site conducts important research.
At Erasmus Universitair Medisch Centrum Rotterdam, clinical research spans both cancer and heart disease, with studies focused on improving treatment outcomes and supporting better disease control. The work includes trials in medical oncology as well as cardiology, reflecting a broad interest in advancing care for serious conditions.
Across these trials, the main emphasis is on testing new therapies and improving how well current treatments work for patients with difficult-to-treat malignancies and cardiovascular conditions.
More sites in RotterdamThe Netherlands
Clinical trials currently enrolling participants at this site.
Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
The NetherlandsThe NetherlandsA Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata
The NetherlandsBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
The NetherlandsA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
The NetherlandsA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
The NetherlandsA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
The NetherlandsA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
The NetherlandsA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
The NetherlandsLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
The NetherlandsStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
The NetherlandsStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
The NetherlandsMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
